Tagged with APACMed

The Challenges of Regulatory Convergence in APAC Medtech

Singapore The Challenges of Regulatory Convergence in APAC Medtech

Singapore Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue, predominantly due to the extreme variation in cultures, economic development, governmental models, and healthcare systems in the region. Greater harmonisation would allow solutions introduced in APAC’s most developed markets to filter down to its…

Medtech’s Post-COVID Paradigm in APAC

Asia-Pacific Medtech’s Post-COVID Paradigm in APAC

Asia-Pacific At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine percent, certainly its most dynamic. Chronic underfunding of healthcare systems in APAC means that a region accounting for 60 percent of the world’s population only represents a quarter of global…

Harjit Gill – CEO, APACMed

Singapore Harjit Gill – CEO, APACMed

Singapore In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association APACMed, how COVID-19 represents a chance to change the global narrative on medtech in healthcare, and the key trends shaping the region’s dynamic market. We often use the term “learning and leapfrogging” in Asia-Pacific,…

Asia-Pacific Healthcare: Managing Diversity

Singapore Asia-Pacific Healthcare: Managing Diversity

Singapore The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life sciences companies. However, the degree of diversity within Asia-Pacific creates formidable challenges for MNCs operating in the region. “APAC is…

Singapore Fredrik Nyberg – CEO, Asia Pacific Medical Technology Association (APACMed), Singapore

Singapore CEO of the Asia Pacific Medical Technology Association (APACMed), Fredrik Nyberg explains the rationale behind the creation of the first regional medical technology association; the industry challenges ahead, and the critical importance of bringing together all industry stakeholders to effectively advance the development of medical technology across Asia Pacific. …

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page